PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$33.01 USD
-0.61 (-1.81%)
Updated May 3, 2024 04:00 PM ET
After-Market: $32.99 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.23 |
EPS Last Quarter | -1.20 |
Last EPS Surprise | 0.83% |
ABR | 2.79 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.36 |
Next Year | -4.62 |
EPS (TTM) | -5.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 152.30M | 144.98M | 683.49M | 658.32M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 176.00M | 163.50M | 845.40M | 843.10M |
Low Estimate | 112.10M | 106.60M | 538.90M | 349.70M |
Year ago Sales | 213.81M | 196.58M | 937.82M | 683.49M |
Year over Year Growth Est. | -28.77% | -26.25% | -27.12% | -3.68% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.23 | -1.69 | -5.36 | -4.62 |
# of Estimates | 8 | 6 | 9 | 8 |
Most Recent Consensus | -1.00 | -1.95 | -4.53 | -6.13 |
High Estimate | -0.98 | -1.33 | -2.88 | -1.51 |
Low Estimate | -1.87 | -2.09 | -7.27 | -6.30 |
Year ago EPS | -2.66 | -1.76 | -3.62 | -5.36 |
Year over Year Growth Est. | 53.76% | 3.98% | -48.07% | 13.91% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 5 | 4 | 7 | 5 |
Up Last 60 Days | 5 | 3 | 6 | 5 |
Down Last 7 Days | 1 | 0 | 1 | 1 |
Down Last 30 Days | 2 | 2 | 2 | 3 |
Down Last 60 Days | 2 | 3 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.23 | -1.69 | -5.36 | -4.62 |
7 Days Ago | -1.18 | -1.69 | -5.14 | -4.56 |
30 Days Ago | -1.40 | -1.72 | -5.95 | -5.36 |
60 Days Ago | -1.39 | -1.66 | -5.85 | -5.27 |
90 Days Ago | -1.63 | -1.73 | -5.88 | -4.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.23 | -1.69 | -5.36 | -4.62 |
Zacks Consensus Estimate | -1.23 | -1.69 | -5.36 | -4.62 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.20 | -0.24 | -1.76 | -2.66 | NA |
Estimate | -1.21 | 0.29 | -0.85 | -1.58 | NA |
Difference | 0.01 | -0.53 | -0.91 | -1.08 | -0.63 |
Surprise | 0.83% | -182.76% | -107.06% | -68.35% | -89.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more